Literature DB >> 12496483

Mismatch repair gene mutations in renal cell carcinoma.

Fredrick S Leach1, Moon Koh, Kirti Sharma, Glenn McWilliams, LaTonia Talifero-Smith, Amanda Codd, Raul Olea, Ossama Elbahloul.   

Abstract

We investigated the spectrum and genetic basis for mismatch repair (MMR) deficiency in renal cell carcinoma (RCC) by examining expression of four MMR genes important for hereditary and sporadic carcinogenesis. MMR deficiency was assessed using microsatellite instability (MSI) and genetic analyses of 25 cell lines derived from renal tumors. MMR gene alterations were detected using reverse transcription of RNA coupled with polymerase chain reaction (RT-PCR) and DNA sequencing. Three RCC lines with undetectable MLH1 were identified and investigated for MSI and inactivating mutations in the hMLH1 MMR gene. Genetic instability and hMLH1 mutations were identified in two RCC lines and their corresponding tumors. Genetic alterations affecting expression were limited to MLH1 since other MMR proteins (MSH2, MSH6 and PMS2) were detectable in our RCC lines. Complete inactivation of MMR is apparently uncommon in RCC and occurs predominantly through inactivating mutations in the hMLH1 gene.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12496483     DOI: 10.4161/cbt.1.5.171

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  3 in total

1.  The extracolonic cancer spectrum in females with the common 'South African' hMLH1 c.C1528T mutation.

Authors:  Maria M Blokhuis; Paul A Goldberg; G Elize Pietersen; Ursula Algar; A Alvera Vorster; Dhiren Govender; Raj S Ramesar
Journal:  Fam Cancer       Date:  2007-11-30       Impact factor: 2.375

2.  Deficiency of MSH2 expression is associated with clear cell renal cell carcinoma.

Authors:  Koo Han Yoo; Kyu Yeoun Won; Sung-Jig Lim; Yong-Koo Park; Sung-Goo Chang
Journal:  Oncol Lett       Date:  2014-08-26       Impact factor: 2.967

Review 3.  The Identification of Immunological Biomarkers in Kidney Cancers.

Authors:  Antonio Lopez-Beltran; Vanessa Henriques; Alessia Cimadamore; Matteo Santoni; Liang Cheng; Thomas Gevaert; Ana Blanca; Francesco Massari; Marina Scarpelli; Rodolfo Montironi
Journal:  Front Oncol       Date:  2018-11-02       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.